Alexis F. Sauer-Budge

About

Alexis F. Sauer-Budge is a pioneering biomedical engineer whose work sits at the intersection of automation, biotechnology, and therapeutic manufacturing. Her most impactful contribution is the development of a first-of-its-kind, fully automated "factory" that leverages tobacco plants and plant viral vector technology to produce vaccines and therapeutic biologics within weeks. This breakthrough, detailed in her highly cited 2012 paper (60 citations), promises to revolutionize the rapid, scalable production of life-saving medicines, bypassing traditional slow and costly methods. Beyond plant-based pharmaceuticals, Sauer-Budge has advanced minimally invasive surgery with an artificial hand prototype and tackled a critical bottleneck in regenerative medicine by designing an automated system for rapid, standardized extraction of viable cells from dense tissues. Her work addresses fundamental challenges in cGMP compliance and scalability, making her a key figure in translating lab discoveries into clinical and commercial realities.

Research Focus

Key Achievements

Top Papers

1. 1
   Automated Production of Plant-Based Vaccines and Pharmaceuticals

   60 citations · 2012
2. 2
   Artificial hand for minimally invasive surgery: design and testing of initial prototype

   8 citations · 2014
3. 3
   Automated Tissue Dissociation for Rapid Extraction of Viable Cells

   5 citations · 2017

Key Collaborators

Contact & Links